SCHEMBL30494101

SCHEMBL30494101

CSC1=N/C(=C\c2ccc3ncn(C)c3c2)C(=O)N1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.57
▸ CYP1A2 P05177 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ CBS P35520 1/20 0.56
▸ DYRK2 Q92630 9/20 0.44
▸ DYRK1A Q13627 8/20 0.44
▸ DYRK1B Q9Y463 8/20 0.44
▸ DYRK3 O43781 6/20 0.44
▸ PIM1 P11309 2/20 0.44
▸ CLK1 P49759 7/20 0.41
▸ CLK4 Q9HAZ1 6/20 0.41
▸ CLK2 P49760 5/20 0.41
▸ DYRK4 Q9NR20 4/20 0.41
▸ CLK3 P49761 3/20 0.41
▸ CDK5 Q00535 3/20 0.41
▸ CDK5R1 Q15078 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26096313 1.00 MAPT (0.57) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26107614 0.81 MAPT (0.61) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL30363432 0.78 MAPT (0.60) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26094464 0.78 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26106872 0.78 MAPT (0.60) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL30494190 0.78 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26096339 0.78 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL30396066 0.78 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26092399 0.78 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL30363334 0.77 MAPT (0.55) MAPTCYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4422753-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2024-09-04 — — EP disclosed
WO-2023072966-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 PERHA PHARMACEUTICALS (FR) 2023-05-04 — — WO disclosed
Send feedback